Vaccine innovations in an age of uncertainty: BCG in France

Tzung-wen Chen

Technology in Society, 2005, vol. 27, issue 1, 39-53

Abstract: The Bacille Calmette–Guérin vaccine (BCG) remains one of the most widely used vaccines against infectious disease since it first appeared in the early 1900s. The development of BCG and its adoption into the vaccination schedule was, however, controversial. This paper reviews the history of BCG innovations, including its development in France, its worldwide diffusion, and its connection with public health policy. The research finds that, while knowledge-centered scientific activities played an important role in vaccine innovations, decision making vis-a-vis public acceptance of the vaccine relies more on the characteristics of the vaccine and is shaped by collective actions taken by diverse social actors. This article provides a community-based framework to explain the collective actions that overcame the uncertainty caused by limitations in technology and knowledge.

Keywords: Vaccine innovation; BCG; Institut Pasteur; Community of innovation (search for similar items in EconPapers)
Date: 2005
References: View references in EconPapers View complete reference list from CitEc
Citations: View citations in EconPapers (1)

Downloads: (external link)
http://www.sciencedirect.com/science/article/pii/S0160791X04000697
Full text for ScienceDirect subscribers only

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:eee:teinso:v:27:y:2005:i:1:p:39-53

DOI: 10.1016/j.techsoc.2004.10.004

Access Statistics for this article

Technology in Society is currently edited by Charla Griffy-Brown

More articles in Technology in Society from Elsevier
Bibliographic data for series maintained by Catherine Liu ().